Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
Chaib, Imane
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. [electronic resource] - Journal of the National Cancer Institute 09 2017
Publication Type: Journal Article
1460-2105
10.1093/jnci/djx014 doi
Adaptor Proteins, Signal Transducing--antagonists & inhibitors
Adenocarcinoma--drug therapy
Adenocarcinoma of Lung
Adult
Aged
Aged, 80 and over
Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cell Line, Tumor
ErbB Receptors--antagonists & inhibitors
Female
Humans
Lung Neoplasms--drug therapy
Male
Mice
Mice, Nude
Middle Aged
Phosphoproteins--antagonists & inhibitors
Protein Kinase Inhibitors--administration & dosage
RNA, Messenger--biosynthesis
Retrospective Studies
STAT3 Transcription Factor--antagonists & inhibitors
Signal Transduction
Transcription Factors
YAP-Signaling Proteins
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. [electronic resource] - Journal of the National Cancer Institute 09 2017
Publication Type: Journal Article
1460-2105
10.1093/jnci/djx014 doi
Adaptor Proteins, Signal Transducing--antagonists & inhibitors
Adenocarcinoma--drug therapy
Adenocarcinoma of Lung
Adult
Aged
Aged, 80 and over
Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cell Line, Tumor
ErbB Receptors--antagonists & inhibitors
Female
Humans
Lung Neoplasms--drug therapy
Male
Mice
Mice, Nude
Middle Aged
Phosphoproteins--antagonists & inhibitors
Protein Kinase Inhibitors--administration & dosage
RNA, Messenger--biosynthesis
Retrospective Studies
STAT3 Transcription Factor--antagonists & inhibitors
Signal Transduction
Transcription Factors
YAP-Signaling Proteins